Edition:
United Kingdom

Invacare Corp (IVC.N)

IVC.N on New York Stock Exchange

17.05USD
12 Jan 2018
Change (% chg)

$0.25 (+1.49%)
Prev Close
$16.80
Open
$16.75
Day's High
$17.05
Day's Low
$16.75
Volume
37,743
Avg. Vol
86,640
52-wk High
$17.95
52-wk Low
$9.90

Select another date:

Fri, Jan 5 2018

BRIEF-Invacare Says On Jan 3, FDA Notified Co That Its Unit Alber GMBH's Responses To Warning Letter Diclosed In Sept 2017 Are "Adequate" - SEC Filing

* INVACARE SAYS ON JAN 3, FDA NOTIFIED CO THAT ITS UNIT ALBER GMBH'S RESPONSES TO WARNING LETTER DICLOSED IN SEPT 2017 ARE "ADEQUATE" - SEC FILING

BRIEF-Invacare Announces North America Reduction In Force As Part Of Continued Cost Realignment

* INVACARE ANNOUNCES NORTH AMERICA REDUCTION IN FORCE AS PART OF CONTINUED COST REALIGNMENT

BRIEF-Invacare announces departure of Chief Financial Officer

* Invacare Corp - ‍while co performs executive search to identify successor to Gudbranson, Kathleen P. Leneghan will assume role of interim CFO​ Source text for Eikon: Further company coverage:

BRIEF-Invacare says ‍Alber GMBH received warning letter from US food and drug administration​

* Invacare Corp - ‍alber GMBH, a wholly owned subsidiary of Invacare Corporation, received warning letter from United States Food And Drug Administration​

BRIEF-Invacare Q2 loss per share $0.72

* Q2 earnings per share view $-0.42 -- Thomson Reuters I/B/E/S

BRIEF-Invacare says will transfer production of wheelchairs to France

* Invacare - will transfer production of Invacare Rea manual wheelchairs from facility in Sweden to manufacturing facility in Fondettes, France by Jan. 2018

BRIEF-Invacare reaches new consent decree milestone

* Invacare says received notice from FDA that co has successfully satisfied requirements to resume full operations at its manufacturing facility in Elyria, Ohio

Select another date: